Form 4: Orchestra BioMed Holdings Executive Reports Stock Transactio
Insider Transaction (Form 4)
David P Hochman, See Remarks and a Director of Orchestra BioMed Holdings, Inc., reported multiple transactions in common stock on September 10, 2026.
Summary
- Tax/exercise-price withholding: disposed of 3,283 Common Stock, par value $0.0001 per share ("Common Stock") at $5.81 ($19,074) on September 10, 2026; holds 1,067,463 after (Direct).
- Tax/exercise-price withholding: disposed of 3,283 Common Stock at $5.81 ($19,074) on September 10, 2026; holds 432,916 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
David P Hochman — Director, Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Tax/exercise-price withholding | Common Stock, par value $0.0001 per share ("Common Stock") | 3,283 | $6 | $19.1K | 1,067,463 |
| 2026-09-10 | Tax/exercise-price withholding | Common Stock | 3,283 | $6 | $19.1K | 432,916 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Tax/exercise-price withholding (3,283 shares) |
| 2026-09-10 | Tax/exercise-price withholding (3,283 shares) |
Keywords
insider transaction, Form 4, OBIO, Orchestra BioMed Holdings, Inc., neutral, David P Hochman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.